HealthcareServices

Sacroiliitis Treatment Market Research: Growth Projections and Trends 2030

March 2, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the sacroiliitis treatment market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Sacroiliitis Treatment Market?

The sacroiliitis treatment market has experienced significant expansion in recent years. This market is projected to increase from $1.77 billion in 2025 to $1.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. The historical rise in this market can be attributed to several factors, including the increasing prevalence of inflammatory spinal disorders, the wider use of diagnostic imaging, an improved understanding of sacroiliac joint pathology, the expansion of pain management clinics, and the availability of advanced pharmacological therapies.

The sacroiliitis treatment market is anticipated to experience robust expansion in the coming years. This market is projected to reach $2.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. Key factors contributing to this growth during the forecast period include the rising acceptance of biologic drugs, a greater need for minimally invasive pain management, the expansion of orthopedic procedures performed on an outpatient basis, the increasing incorporation of digital diagnostics, and an enhanced emphasis on restoring long-term mobility. Notable trends expected throughout the forecast period encompass the augmented utilization of image-guided diagnostic methods, an uptick in the adoption of minimally invasive SI joint fusion, an evolving preference for biologic and targeted therapeutic options, the broadening of radiofrequency-based pain management strategies, and a heightened focus on individualized treatment plans.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24688&type=smp

Which Drivers Are Supporting The Rise Of The Sacroiliitis Treatment Market?

The future expansion of the sacroiliitis treatment market is anticipated to be driven by the rising occurrence of joint disorders. These conditions, which involve pain, inflammation, stiffness, and restricted movement in the joints, stem from causes such as injury, aging, autoimmune diseases, or infections. The growing prevalence of joint disorders is largely attributable to the natural deterioration of joints in aging populations, leading to an increased incidence of conditions like osteoarthritis and other degenerative joint ailments. Sacroiliitis treatment offers benefits for joint disorders by alleviating inflammation and pain in the sacroiliac joints, thereby enhancing mobility and overall joint function, which can ease symptoms and prevent further damage. A relevant illustration is the data from February 2024, provided by Arthritis Australia, an Australia-based non-profit organization, indicating that in 2025, osteoarthritis (OA) is predicted to impact 2.35 million Australians (Figure 2), constituting 57% of the total arthritis population and establishing it as the most common type of arthritis nationwide. Furthermore, by 2040, the count of Australians suffering from OA is projected to climb to 3.11 million, marking a 32% increase from 2025. This means an additional 762,515 individuals in Australia will be living with OA by 2040 compared to 2025. Consequently, the escalating rates of joint disorders are fueling the demand within the sacroiliitis treatment market.

What Leading Segments Are Studied In The Sacroiliitis Treatment Market?

The sacroiliitis treatment market covered in this report is segmented –

1) By Type: Medications, Joint Injections, Joint Fusion, Radiofrequency Denervation, Electrical Stimulation

2) By Diagnosis: Imaging Tests, Physical Examination, Laboratory Tests, Other Diagnosis

3) By Route Of Administration: Oral, Injectable, Topical

4) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Medications: NSAIDs (Nonsteroidal Anti-Inflammatory Drugs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Agents, Analgesics

2) By Joint Injections: Corticosteroid Injections, Platelet-Rich Plasma (PRP) Injections, Hyaluronic Acid Injections, Prolotherapy

3) By Joint Fusion: Minimally Invasive SI Joint Fusion, Open SI Joint Fusion, Robotic-Assisted Fusion Techniques, Posterior Approach Fusion, Lateral Approach Fusion

4) By Radiofrequency Denervation: Conventional Radiofrequency Ablation, Cooled Radiofrequency Ablation, Pulsed Radiofrequency Ablation

5) By Electrical Stimulation: Transcutaneous Electrical Nerve Stimulation (TENS), Spinal Cord Stimulation (SCS), Peripheral Nerve Stimulation (PNS)

Which Trends Are Guiding The Evolution Of The Sacroiliitis Treatment Market?

Leading companies within the sacroiliitis treatment market are concentrating their efforts on securing regulatory approvals. This strategic focus aims to expedite the introduction of innovative therapies, facilitate market access, and bolster their competitive standing. Regulatory approvals denote the official authorization granted by government health agencies, confirming a medical treatment’s safety and effectiveness for public consumption. For example, in December 2023, Spinal Simplicity, a US-based medical equipment manufacturer, was granted FDA 510(k) clearance for its Liberty-SI Lateral Implant System. This system is a minimally invasive, transfixing device designed for sacroiliac joint fusion in patients presenting with conditions such as sacroiliac disruptions and degenerative sacroiliitis. The system employs a lateral approach, where one or two titanium implants are inserted through the ilium, across the SI joint, and into the sacrum, thereby providing stabilization and fusion. The implants feature a central threaded body with deployable wings and compressive elements, are offered in multiple sizes, and are coated with hydroxyapatite to enhance integration. This procedure is envisioned to be safer and less invasive, potentially reducing anesthesia duration and improving patient outcomes.

Which Leading Companies Dominate The Sacroiliitis Treatment Market Share?

Major companies operating in the sacroiliitis treatment market are Pfizer Inc, Johnson And Johnson, AbbVie Inc, Novartis AG, Eli Lilly And Company, Boehringer Ingelheim International GmbH, Amgen Inc, Biogen Inc, Sandoz Group AG, UCB SA, Hikma Pharmaceuticals PLC, Samsung Bioepis Co Ltd, Lupin Limited, Zydus Lifesciences Limited, Celltrion Healthcare Co Ltd, Torrent Pharmaceuticals Limited, Globus Medical, Orthofix Medical Inc, Coherus BioSciences Inc, SI BONE Inc, Medtronic plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/sacroiliitis-treatment-global-market-report

How Does The Sacroiliitis Treatment Market Perform Across Major Global Regions?

North America was the largest region in the sacroiliitis treatment market in2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacroiliitis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Sacroiliitis Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24688&type=smp

Browse Through More Reports Similar to the Global Sacroiliitis Treatment Market 2026, By The Business Research Company

Psoriatic Arthritis Treatments Market Report 2026

https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

Diverticulitis Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report

Neutropenia Biologic Drug Treatments Market Report 2026

https://www.thebusinessresearchcompany.com/report/neutropenia-biologic-drug-treatments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795